AT298664B - Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper - Google Patents

Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper

Info

Publication number
AT298664B
AT298664B AT25971A AT25971A AT298664B AT 298664 B AT298664 B AT 298664B AT 25971 A AT25971 A AT 25971A AT 25971 A AT25971 A AT 25971A AT 298664 B AT298664 B AT 298664B
Authority
AT
Austria
Prior art keywords
human
restoration
destroyed
damaged
production
Prior art date
Application number
AT25971A
Other languages
German (de)
English (en)
Original Assignee
Braun Fa B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Fa B filed Critical Braun Fa B
Application granted granted Critical
Publication of AT298664B publication Critical patent/AT298664B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0035—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Dentistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Materials For Medical Uses (AREA)
AT25971A 1970-02-02 1971-01-14 Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper AT298664B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2004553 1970-02-02

Publications (1)

Publication Number Publication Date
AT298664B true AT298664B (de) 1972-05-25

Family

ID=5761154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT25971A AT298664B (de) 1970-02-02 1971-01-14 Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper

Country Status (13)

Country Link
AT (1) AT298664B (fi)
BR (1) BR7100718D0 (fi)
CH (1) CH557167A (fi)
DE (1) DE2004553B1 (fi)
DK (1) DK127663B (fi)
ES (1) ES387801A1 (fi)
FI (1) FI54217C (fi)
FR (1) FR2112171B1 (fi)
GB (1) GB1274409A (fi)
IT (1) IT983092B (fi)
NL (1) NL148801B (fi)
NO (1) NO129120B (fi)
SE (1) SE379920B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2944278C2 (de) * 1979-11-02 1983-07-21 Karl Eugen Prof. Dr.med. 7302 Ostfildern Theurer Verfahren zur schonenden Sterilisation von biologischen Wirkstoffen, insbesondere von Organgeweben für therapeutische Zwecke gegenüber Mikroorganismen und Viren
ATE13477T1 (de) * 1981-07-02 1985-06-15 Intermedicat Gmbh Verfahren zur herstellung von skleroproteintransplantaten mit erhoehter biologischer stabilitaet.
GB2150811B (en) * 1983-12-06 1987-04-08 Ethicon Inc Surgical training aid
GB8807187D0 (en) * 1988-03-25 1988-04-27 Harrison J F Improvements in/relating to inactivation of infectious agents
EP0424159A3 (en) * 1989-10-19 1991-11-06 Osteotech, Inc., Aseptic processing of allograft bone and tissue
DE10217779A1 (de) 2002-04-18 2003-11-13 Co Don Ag Konservierte Gewebematrix eines Hohlorganes, insbesondere eines Blutgefäßes, Verfahren zur Herstellung und Verwendung dieser
IN2014DN09993A (fi) * 2012-05-09 2015-08-14 Icrom Spa

Also Published As

Publication number Publication date
FI54217B (fi) 1978-07-31
CH557167A (de) 1974-12-31
DE2004553B1 (de) 1971-05-19
FR2112171A1 (fi) 1972-06-16
NO129120B (fi) 1974-03-04
NL148801B (nl) 1976-03-15
DK127663B (da) 1973-12-17
ES387801A1 (es) 1974-01-16
FI54217C (fi) 1978-11-10
SE379920B (fi) 1975-10-27
BR7100718D0 (pt) 1973-04-19
FR2112171B1 (fi) 1974-04-12
GB1274409A (en) 1972-05-17
IT983092B (it) 1974-10-31
NL7101140A (fi) 1971-08-04

Similar Documents

Publication Publication Date Title
IT1040521B (it) Composizione di metalcrilato oraca ai raggi x particolarmente adatta per la costruzione di protesi da incorporare in tessuti anatomici umani od animali e relativo procedimento di produzione
CH472219A (de) Hochporöse Kollagen-Gewebe-Blutgefässprothese und Verfahren zur Herstellung derselben
ATE110255T1 (de) Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.
AT338034B (de) Verfahren zur behandlung oder verhutung von ruhr bei haustieren
AT297227B (de) Verfahren zur färbenden Behandlung menschlicher Haare sowie Mittel zur Durchführung des Verfahrens
AT299453B (de) Verfahren zur färbenden Behandlung menschlicher Haar sowie Mittel zur Durchführung des Verfahrens
CH540686A (de) Zahnseidenstück sowie Verfahren und Vorrichtung zur Herstellung desselben
AT298664B (de) Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper
CH542445A (de) Diagnostisches Mittel und dessen Verwendung zur Bestimmung der Aktivität von Pankreas-Enzymen im lebenden menschlichen Körper
CH522617A (de) Verfahren zur Herstellung von Thioureidobenzolen sowie deren Verwendung in fungiziden und akariziden Mitteln
AT331421B (de) Verfahren zur desinfektion von menschlicher oder tierischer haut, aber auch von keimfrei zum einsatz zu gelangenden gegenstanden
AT303009B (de) Verfahren zur Herstellung von neuem racemischem oder optisch aktivem 1-(2'-Nitrilophenoxy)-2-hydroxy-3-äthylaminopropan und von dessen Säureadditionssalzen
AT306246B (de) Verfahren zur färbenden Behandlung menschlicher Haare, sowie Mittel zur Durchführung des Verfahrens
CH391178A (de) Verfahren und Vorrichtung zur Ermittlung des Durchblutungsgrades von Teilen des menschlichen oder tierischen Körpers
AT322831B (de) Verfahren und vorrichtung zur herstellung von einen öffnungshals aufweisenden hohlkörpern
AT306248B (de) Verfahren zur färbenden Behandlung menschlicher Haare sowie Mittel zur Durchführung des Verfahrens
AT306247B (de) Verfahren zur färbenden Behandlung menschlicher Haare sowie Mittel zur Durchführung des Verfahrens
AT306245B (de) Verfahren zur färbenden Behandlung menschlicher Haare und Mittel zur Durchführung des Verfahrens
AT306249B (de) Verfahren zur färbenden Behandlung menschlicher Haare und Mittel zur Durchführung des Verfahrens
AT309402B (de) Verfahren zur Herstellung von (S) (-) 2-[(S)(α-Phenyläthyl)amino]-butan-1-ol und dessen Säureadditionssalzen
CH548989A (de) Verfahren zur herstellung von formamidin-derivaten und deren verwendung als insektizide oder milbentoetende mittel.
AT320872B (de) Verfahren zur Herstellung von in den 9(11)- und/oder 16-Stellungen ungesättigten Steroiden
CH541608A (de) Verfahren zur Herstellung von Nitrodiphenylaminen und deren Verwendung
CH554317A (de) Verfahren zur herstellung von (alpha)-(aminoalkyl)-4-hydroxy3-uroidobenzylalkoholen und ihren saeureadditionssalzen.
GB1365119A (en) Treatment of animal tissues for removing biologically and physio logically active substances which are soluble in fats or in water and a method of preparing a cosmetic from the residue

Legal Events

Date Code Title Description
EFA Change in the company name
ELJ Ceased due to non-payment of the annual fee